基于Granada-Ⅱ分类法评价丁苯酞氯化钠注射液临床应用中存在的药物相关问题
Evaluation of drug-related problems in clinical application of butylphthalide and sodium chloride injection based on Granada-Ⅱ classification
张鹏程 1王雪倩 1赵欢欢 1刘丽 1孟冰冰 1陈慧娟 1宋佳伟1
作者信息
- 1. 安徽省亳州市人民医院临床药学中心,亳州 236800
- 折叠
摘要
目的 探讨丁苯酞氯化钠注射液临床应用中存在的药物相关问题(DRPs),促进合理用药.方法 利用美康合理用药系统(Pharm Assist),抽取医院2022年7月1日至2023年6月30日出院患者中使用丁苯酞氯化钠注射液病历145份,采用Granada-Ⅱ分类法对患者住院期间使用丁苯酞氯化钠注射液的必要性、有效性及安全性进行研究.结果 共有145例患者使用了丁苯酞氯化钠注射液,其中93例(64.14％)发生了 DRPs,累计发生131例次DRPs,包括57例次(43.51％)DRP4,64例次(48.86％)DRP5,10例次(7.63％)DRP6.结论 丁苯酞氯化钠注射液的DRPs主要是安全性与有效性问题.药师需加强对丁苯酞氯化钠注射液临床应用DRPs的干预,促进临床合理用药.
Abstract
AIM To investigate the drug-related problems(DRPs)in the clinical application of butylphthalide and sodium chloride injection in order to promote rational drug use.METHODS Through the rational drug use system of Meikang(Pharm Assist),a total of 145 medical records using butylphthalide and sodium chloride injection were selected from patients discharged from the hospital from July 1,2022 to June 30,2023.The necessity,effectiveness and safety of butylphthalide and sodium chloride injection in clinical application were studied with reference to Granada-Ⅱ classification.RESULTS DRPs occurred in 93(64.14％)cases of 145 medical records of butylphthalide and sodium chloride injection.The DRPs were generated 131 case-times in total,including 57 case-times(43.51％)DRP4,64 case-times(48.86％)DRP5 and 10 case-times(7.63％)DRP6.CONCLUSION The DRPs of butylphthalide and sodium chloride injection are mainly problems of safety and efficacy.Pharmacists should strengthen the intervention in DRPs of clinical application of butylphthalide and sodium chloride injection to promote clinical rational drug use.
关键词
丁苯酞氯化钠注射液/药物相关问题/合理用药/Granada-Ⅱ分类法Key words
butylphthalide and sodium chloride injection/drug-related problems/rational drug use/Granada-Ⅱclassification引用本文复制引用
出版年
2024
国家科技期刊平台
NSTL
万方数据